Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,180,564 papers from all fields of science
Search
Sign In
Create Free Account
Stage III Renal Cell Cancer AJCC v7
Known as:
Stage III Renal Cell Cancer
, Stage III Renal Cell Carcinoma
, Stage III Renal Cell Carcinoma AJCC v7
Stage III includes: (T1 or T2, N1, M0); (T3, N0 or N1, M0). T1: Lesions have been divided into T1a and T1b. T1a is defined as tumor 4 cm or less in…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
15 relations
Epithelial Cells
Epithelium
Flank Pain
Hematuria
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Reassessment of American Joint Committee on Cancer Staging for Stage III Renal Cell Carcinoma With Nodal Involvement: Propensity Score Matched Analyses of a Large Population-Based Study
Jianglong Han
,
Qin Li
,
+5 authors
Zhenming Fu
Frontiers in Oncology
2020
Corpus ID: 212748306
Background: To assess the role of nodal involvement in stage III renal cell carcinoma (RCC) according to the American Joint…
Expand
2019
2019
Construction and Validation of a 9-Gene Signature for Predicting Prognosis in Stage III Clear Cell Renal Cell Carcinoma
Junlong Wu
,
Shengming Jin
,
+5 authors
D. Ye
Frontiers in Oncology
2019
Corpus ID: 81985170
Purpose: Aim of this study was to develop a multi-gene signature to help better predict prognosis for stage III renal cell…
Expand
2019
2019
MP14-20 IMPACT OF PATHOLOGIC NODE POSITIVE RENAL CELL CARCINOMA ON SURVIVAL IN PATIENTS WITHOUT METASTASIS: EVIDENCE IN SUPPORT OF EXPANDING THE DEFINITION OF STAGE IV KIDNEY CANCER
A. Srivastava
,
Z. Rivera-Núñez
,
+13 authors
E. Singer
Journal of Urology
2019
Corpus ID: 149753022
INTRODUCTION AND OBJECTIVES: Stage III renal cell carcinoma (RCC) encompasses both node-positive (pT1-3N1M0) and node-negative…
Expand
2015
2015
Efficacy comparison for the treatment of stage III renal cell carcinoma; Transcatheter renal arterial embolization combined with cryoablation vs. sorafenib
Chang-fu Liu
,
Zhi Guo
,
W. Xing
,
Fang Liu
,
T. Si
,
Xueling Yang
2015
Corpus ID: 79262899
2012
2012
76 Clinical and immunological monitoring of a multi-peptide vaccination trial in patients with stage III renal cell carcinoma
J. Bedke
,
Karoline Laske
,
+7 authors
A. Stenzl
2012
Corpus ID: 72168156
Review
2004
Review
2004
[Renal cell carcinoma metastatic to the base of tongue: a case report].
A. Kyan
,
Shin-nosuke Kato
Hinyokika kiyo. Acta urologica Japonica
2004
Corpus ID: 34453913
A 66-year-old male patient underwent left radical nephrectomy for stage III renal cell carcinoma (RCC) two years and eight months…
Expand
Review
2001
Review
2001
HSPPC-96: a personalised cancer vaccine
M. Caudill
,
Zihai Li
Expert Opinion on Biological Therapy
2001
Corpus ID: 9968845
HSPPC-96 is a protein peptide complex consisting of a 96 kDa heat shock protein (Hsp), gp96, and an array of gp96-associated…
Expand
Highly Cited
1999
Highly Cited
1999
Successful treatment of metastatic renal cell carcinoma with a nonmyeloablative allogeneic peripheral-blood progenitor-cell transplant: evidence for a graft-versus-tumor effect.
R. Childs
,
E. Clave
,
J. Tisdale
,
M. Plante
,
N. Hensel
,
J. Barrett
Journal of Clinical Oncology
1999
Corpus ID: 19894202
PURPOSE A 50-year-old man developed progressive pulmonary metastasis resistant to interferon alfa-2b treatment 7 months after he…
Expand
1997
1997
The results of postoperative radiotherapy in patients with renal cell carcinoma in third stage of clinical advancement based on data of Greatpoland Cancer Centre
M. Matecka-Nowak
,
E. Adamiak
,
G. Stryczyńska
1997
Corpus ID: 58141395
1987
1987
Management of locally recurrent renal cell carcinoma after partial nephrectomy.
A. Novick
,
R. Straffon
Journal of Urology
1987
Corpus ID: 32675912
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE